首页> 外文期刊>Medicine. >Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associ
【24h】

Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associ

机译:胃肠炎累及全身坏死性血管炎的表现及结果:对62例结节性多发性动脉炎,镜下性多发性血管炎,韦格纳肉芽肿病,Churg-Strauss综合征或类风湿性关节炎相关患者的分析

获取原文
获取原文并翻译 | 示例
           

摘要

We reviewed the medical records of 62 patients with systemic small and medium-sized vessel vasculitides and gastrointestinal tract involvement followed at our institution between 1981 and 2002. This group included 46 men and 16 women (male:female ratio, 2.9), with a mean age of 48 +/- 18 years. Vasculitides were distributed as follows: 38 polyarteritis nodosa (21 related to hepatitis B virus), 11 Churg-Strauss syndrome, 6 Wegener granulomatosis, 4 microscopic polyangiitis, and 3 rheumatoid arthritis-associated vasculitis. Gastrointestinal manifestations were present at or occurred within 3 months of diagnosis in 50 (81%) patients and were mainly abdominal pain in 61 (97%), nausea or vomiting in 21 (34%), diarrhea in 17 (27%), hematochezia or melena in 10 (16%), and hematemesis in 4 (6%). Gastroduodenal ulcerations were detected endoscopically in 17 (27 %) patients, esophageal in 7 (11%), and colorectal in 6 (10%), but histologic signs of vasculitis were found in only 3 colon biopsies. Twenty-one (34%) patients had a surgical abdomen; 11 (18%) developed peritonitis, 9 (15%) had bowel perforations, 10 (16%) bowel ischemia/infarction, 4 (6%) intestinal occlusion, 6 (10%) acute appendicitis, 5 (8%) cholecystitis, and 3 (5%) acute pancreatitis. (Some patients had more than 1 condition.) Sixteen (26%) patients died.The respective 10-month and 5-year survival rates were 71% (95% confidence interval [CI], 52-90) and 56% (95% CI, 35-77) for the 21 surgical patients; and 94% (95% CI, 87-101) and 82% (95% CI, 70-94) for the 41 patients without surgical abdomen (p = 0.08). Peritonitis (hazard ratio [HR] = 4.3, p < 0.01), bowel perforations (HR = 5.7, p < 0.01), gastrointestinal ischemia or infarctions (HR = 4.1, p < 0.01), and intestinal occlusion (HR = 5.5, p < 0.01) were the only gastrointestinal manifestations significantly associated with increased mortality in multivariate analysis. For this subgroup of 15 patients, 6-month and 5-year survival rates were 60% (95% CI, 35-85) and 46% (95% CI, 19-73), respectively (p = 0.003). None of the other gastrointestinal or extraintestinal vasculitis-related symptoms, or angiographic abnormalities (seen in 67% of the 39 patients who underwent angiography), was predictive of surgical complications or poor outcome. However, prognosis has dramatically improved during the past 30 years, probably owing to better management of these more severely ill patients, with prompt surgical intervention when indicated, and the combined use of steroids and immunosuppressants.
机译:我们回顾了1981年至2002年在我院就诊的62例全身性中小血管血管炎和胃肠道受累患者的病历。该组包括46名男性和16名女性(男性:女性比例为2.9),平均年龄48 +/- 18岁。血管炎的分布如下:结节性多发性动脉炎38例(与乙型肝炎病毒有关),11例Churg-Strauss综合征,6例Wegener肉芽肿病,4例显微镜下的多发性血管炎和3例类风湿关节炎相关的血管炎。确诊或在3个月内出现胃肠道表现的患者有50(81%),主要是腹痛61(97%),恶心或呕吐21(34%),腹泻17(27%),便血或黑便10例(16%),呕血4例(6%)。内窥镜检查发现胃十二指肠溃疡17例(27%),食管癌7例(11%),结直肠癌6例(10%),但只有3例结肠活检发现血管炎的组织学征象。 21名(34%)的患者有手术腹部; 11例(18%)的发展性腹膜炎,9例(15%)的肠穿孔,10例(16%)肠缺血/梗塞,4例(6%)肠阻塞,6例(10%)急性阑尾炎,5例(8%)胆囊炎, 3例(5%)急性胰腺炎。 (某些患者有1种以上的疾病。)16名(26%)患者死亡。分别的10个月和5年生存率分别为71%(95%置信区间[CI],52-90)和56%(95%) %CI,35-77),用于21名手术患者; 41例无手术腹部的患者为94%(95%CI,87-101)和82%(95%CI,70-94)(p = 0.08)。腹膜炎(危险比[HR] = 4.3,p <0.01),肠穿孔(HR = 5.7,p <0.01),胃肠道缺血或梗塞(HR = 4.1,p <0.01)和肠梗阻(HR = 5.5,p <0.01)是唯一与多变量分析中死亡率增加显着相关的胃肠道表现。对于这个由15名患者组成的亚组,其6个月和5年生存率分别为60%(95%CI,35-85)和46%(95%CI,19-73)(p = 0.003)。没有其他胃肠道或肠外血管炎相关症状或血管造影异常(在接受血管造影的39例患者中有67%见)可预测手术并发症或预后不良。然而,在过去的30年中,预后得到了显着改善,这可能是由于这些重症患者的治疗得到了更好的控制,并在指示时及时进行了手术干预,以及类固醇和免疫抑制剂的联合使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号